205 related articles for article (PubMed ID: 23939901)
1. Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo.
da Silva CF; Batista Dda G; De Araújo JS; Batista MM; Lionel J; de Souza EM; Hammer ER; da Silva PB; De Mieri M; Adams M; Zimmermann S; Hamburger M; Brun R; Schühly W; Soeiro Mde N
Antimicrob Agents Chemother; 2013 Nov; 57(11):5307-14. PubMed ID: 23939901
[TBL] [Abstract][Full Text] [Related]
2. Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).
Sülsen VP; Frank FM; Cazorla SI; Anesini CA; Malchiodi EL; Freixa B; Vila R; Muschietti LV; Martino VS
Antimicrob Agents Chemother; 2008 Jul; 52(7):2415-9. PubMed ID: 18443111
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
[TBL] [Abstract][Full Text] [Related]
5. Mode of Action of the Sesquiterpene Lactones Psilostachyin and Psilostachyin C on Trypanosoma cruzi.
Sülsen VP; Puente V; Papademetrio D; Batlle A; Martino VS; Frank FM; Lombardo ME
PLoS One; 2016; 11(3):e0150526. PubMed ID: 26939119
[TBL] [Abstract][Full Text] [Related]
6. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
[TBL] [Abstract][Full Text] [Related]
7. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruzi.
Ramírez-Macías I; Marín C; Chahboun R; Messouri I; Olmo F; Rosales MJ; Gutierrez-Sánchez R; Alvarez-Manzaneda E; Sánchez-Moreno M
Am J Trop Med Hyg; 2012 Sep; 87(3):481-8. PubMed ID: 22802442
[TBL] [Abstract][Full Text] [Related]
9. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA
Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737
[TBL] [Abstract][Full Text] [Related]
10. Biological approaches to characterize the mode of action of two 5-nitroindazolinone prototypes on Trypanosoma cruzi bloodstream trypomastigotes.
Fonseca-Berzal C; DA Silva CF; Menna-Barreto RF; Batista MM; Escario JA; Arán VJ; Gómez-Barrio A; Soeiro Mde N
Parasitology; 2016 Sep; 143(11):1469-78. PubMed ID: 27312370
[TBL] [Abstract][Full Text] [Related]
11. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
[TBL] [Abstract][Full Text] [Related]
12.
Santos CC; Lionel JR; Peres RB; Batista MM; da Silva PB; de Oliveira GM; da Silva CF; Batista DGJ; Souza SMO; Andrade CH; Neves BJ; Braga RC; Patrick DA; Bakunova SM; Tidwell RR; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203486
[TBL] [Abstract][Full Text] [Related]
13. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
Scalise ML; Arrúa EC; Rial MS; Esteva MI; Salomon CJ; Fichera LE
Am J Trop Med Hyg; 2016 Aug; 95(2):388-93. PubMed ID: 27246447
[TBL] [Abstract][Full Text] [Related]
14. Activity of the sesquiterpene lactone goyazensolide against
Milagre MM; Branquinho RT; Gonçalves MF; de Assis G; de Oliveira MT; Reis L; Saúde-Guimarães DA; de Lana M
Parasitology; 2020 Jan; 147(1):108-119. PubMed ID: 31455451
[TBL] [Abstract][Full Text] [Related]
15. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
16. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi.
da Silva CF; Batista MM; Batista Dda G; de Souza EM; da Silva PB; de Oliveira GM; Meuser AS; Shareef AR; Boykin DW; Soeiro Mde N
Antimicrob Agents Chemother; 2008 Sep; 52(9):3307-14. PubMed ID: 18625779
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.
Matsuo AL; Silva LS; Torrecilhas AC; Pascoalino BS; Ramos TC; Rodrigues EG; Schenkman S; Caires AC; Travassos LR
Antimicrob Agents Chemother; 2010 Aug; 54(8):3318-25. PubMed ID: 20479201
[TBL] [Abstract][Full Text] [Related]
20. Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas disease.
Bahia MT; Nascimento AF; Mazzeti AL; Marques LF; Gonçalves KR; Mota LW; Diniz Lde F; Caldas IS; Talvani A; Shackleford DM; Koltun M; Saunders J; White KL; Scandale I; Charman SA; Chatelain E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4362-70. PubMed ID: 24841257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
